Eli Lilly Current Ratio 2006-2019 | LLY

Current and historical current ratio for Eli Lilly (LLY) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Eli Lilly current ratio for the three months ending December 31, 2019 was .
Eli Lilly Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-12-31 $0.00B 0.00
2019-09-30 $12.66B $10.83B 1.17
2019-06-30 $13.46B $11.86B 1.14
2019-03-31 $12.60B $11.24B 1.12
2018-12-31 $20.55B $11.89B 1.73
2018-09-30 $20.69B $10.83B 1.91
2018-06-30 $18.33B $13.06B 1.40
2018-03-31 $16.26B $11.55B 1.41
2017-12-31 $19.20B $14.54B 1.32
2017-09-30 $17.43B $12.67B 1.38
2017-06-30 $15.75B $11.30B 1.39
2017-03-31 $12.98B $10.45B 1.24
2016-12-31 $15.10B $10.99B 1.38
2016-09-30 $13.39B $8.27B 1.62
2016-06-30 $12.98B $8.40B 1.55
2016-03-31 $11.72B $7.34B 1.60
2015-12-31 $12.57B $8.23B 1.53
2015-09-30 $12.57B $8.30B 1.51
2015-06-30 $12.35B $8.23B 1.50
2015-03-31 $11.74B $8.34B 1.41
2014-12-31 $11.93B $9.74B 1.23
2014-09-30 $12.11B $7.58B 1.60
2014-06-30 $13.16B $7.42B 1.77
2014-03-31 $13.04B $6.63B 1.97
2013-12-31 $13.11B $8.92B 1.47
2013-09-30 $13.20B $8.08B 1.64
2013-06-30 $12.64B $8.41B 1.50
2013-03-31 $12.33B $7.59B 1.62
2012-12-31 $13.04B $8.39B 1.55
2012-09-30 $14.04B $6.96B 2.02
2012-06-30 $12.31B $6.61B 1.86
2012-03-31 $12.60B $6.55B 1.92
2011-12-31 $14.25B $8.93B 1.60
2011-09-30 $14.57B $8.22B 1.77
2011-06-30 $14.95B $8.62B 1.73
2011-03-31 $15.35B $7.65B 2.01
2010-12-31 $14.84B $6.93B 2.14
2010-09-30 $14.18B $6.10B 2.33
2010-06-30 $12.47B $6.33B 1.97
2010-03-31 $12.25B $5.66B 2.17
2009-12-31 $12.49B $6.57B 1.90
2009-09-30 $11.81B $6.07B 1.95
2009-06-30 $10.94B $6.99B 1.57
2009-03-31 $10.26B $7.36B 1.40
2008-12-31 $12.45B $13.11B 0.95
2008-09-30 $12.95B $6.51B 1.99
2008-06-30 $12.68B $5.26B 2.41
2008-03-31 $12.49B $4.16B 3.00
2007-12-31 $12.32B $5.44B 2.27
2007-09-30 $10.45B $4.07B 2.57
2007-06-30 $9.56B $4.55B 2.10
2007-03-31 $9.25B $4.15B 2.23
2006-12-31 $9.69B $5.09B 1.91
2006-09-30 $9.77B $3.88B 2.52
2006-06-30 $10.59B $4.65B 2.28
2006-03-31 $10.36B $4.53B 2.29
2005-12-31 $10.80B $5.72B 1.89
2005-09-30 $11.95B $5.09B 2.35
2005-06-30 $10.95B $6.46B 1.70
2005-03-31 $11.26B $5.38B 2.09
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $135.806B $22.320B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.914B 17.09
Roche Holding AG (RHHBY) Switzerland $300.375B 0.00
Novartis AG (NVS) Switzerland $220.677B 18.38
Merck (MRK) United States $210.018B 15.89
Pfizer (PFE) United States $198.398B 12.15
Novo Nordisk (NVO) Denmark $150.392B 25.82
AbbVie (ABBV) United States $139.349B 10.54
AstraZeneca (AZN) United Kingdom $128.407B 27.65
Sanofi (SNY) France $127.085B 15.10
GlaxoSmithKline (GSK) United Kingdom $106.698B 13.53
Bristol-Myers Squibb (BMY) United States $106.180B 13.95
Bayer (BAYRY) Germany $75.462B 11.18
H Lundbeck (HLUYY) Denmark $7.744B 13.45